(Q34975851)

5 August 2017

1 reference

title

Alteration of histological gastritis after cure of Helicobacter pylori infection (English)

1 reference

Helicobacter pylori infectious disease

5 August 2017

0 references

1 reference

Hojo M

1

1 reference

5 August 2017

Miwa H

2

1 reference

5 August 2017

Ohkusa T

3

1 reference

5 August 2017

Ohkura R

4

1 reference

5 August 2017

Kurosawa A

5

1 reference

5 August 2017

Sato N

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Alimentary Pharmacology & Therapeutics

5 August 2017

1 reference

5 August 2017

16

1 reference

5 August 2017

11

1 reference

5 August 2017

1923-1932

1 reference

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

5 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

The Sydney System: histological division

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Effect of Helicobacter pylori eradication on gastric mucosal phospholipid content and its fatty acid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Effect of Helicobacter pylori infection on gastric juice pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Reversal of fundic atrophy after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Atrophic body gastritis: distinct features associated with Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Helicobacter pylori infection and chronic gastric acid hyposecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Chronic active gastritis after eradication of Campylobacter (now: Helicobacter) pylori. Results of a medium term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Long-term follow-up of gastric histology after Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Expression of cyclooxygenase-2 and nitrotyrosine in human gastric mucosa before and after Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Effects of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Severity of Helicobacter pylori gastritis predicts duodenal ulcer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Review article: Gastric atrophy and atrophic gastritis--nebulous concepts in search of a definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

Antigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01346.X

10.1046/J.1365-2036.2002.01346.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference